Structures by: Martin S.
Total: 6
BMS-791325
C36H46ClN5O6S
Journal of medicinal chemistry (2014) 57, 5 1855-1879
a=28.0870(13)Å b=11.9998(6)Å c=10.9846(6)Å
α=90.00° β=90.761(2)° γ=90.00°
(C11H26N1),(Cl1),(H2O)
(C11H26N1),(Cl1),(H2O)
Acta Crystallographica Section C (1996) 52, 5 1261-1263
a=7.701(2)Å b=40.020(5)Å c=4.6437(6)Å
α=90.° β=107.34(1)° γ=90.°
(N-<i>tert</i>-Butylpyrazine-2-carboxamide- κN^4^)chloridobis(dimethylglyoximato-κ^2^N,N)cobalt(III) hemihydrate
C17H27ClCoN7O5,0.5(H2O)
Acta Crystallographica Section E (2007) 63, 11 m2670-m2670
a=11.4320(2)Å b=15.8134(4)Å c=26.2781(6)Å
α=90.00° β=90.06(2)° γ=90.00°
2-Aminopyridinium <i>trans</i>-diaquabis(oxalato-κ^2^<i>O</i>,<i>O</i>)chromate(III)
C4H4CrO10,C5H7N2
Acta Crystallographica Section E (2012) 68, 11 m1325-m1326
a=6.8627(14)Å b=19.434(4)Å c=9.854(2)Å
α=90.00° β=99.90(3)° γ=90.00°
C23H26BCo2F4N7O7
C23H26BCo2F4N7O7
Inorganic Chemistry (2001) 40, 4550-4555
a=13.537(3)Å b=11.077(2)Å c=19.941(7)Å
α=90.00° β=90.19(3)° γ=90.00°
C25H20Co2N6O6
C25H20Co2N6O6
Inorganic Chemistry (2001) 40, 4550-4555
a=13.0395(13)Å b=12.3033(13)Å c=19.3648(15)Å
α=90.00° β=122.575(9)° γ=90.00°